Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
מצבים רפואיים
Resectable Intrahepatic Cholangiocarcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
Contact: Principal Investigator (Zeljka Jutric)Los Angeles General Medical Center, Los Angeles, California, United States
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
Contact: Principal Investigator (Zeljka Jutric)UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Sarah L. Davis)Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Yale University, New Haven, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States
Contact: Principal Investigator (Raghav Sundar)UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States
Contact: Principal Investigator (Ali Zarrinpar)Emory University Hospital Midtown, Atlanta, Georgia, United States
Contact: Principal Investigator (Seth Concors)Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Seth Concors)Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Seth Concors)Northwestern University, Chicago, Illinois, United States
Contact: Principal Investigator (Aparna Kalyan)Memorial Hospital East, Shiloh, Illinois, United States
Contact: Principal Investigator (Olivia Aranha)University of Kansas Clinical Research Center, Fairway, Kansas, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Cancer Center, Kansas City, Kansas, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States
Contact: Principal Investigator (Raed Al-Rajabi)Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States
Contact: Principal Investigator (Jonathan D. Mizrahi)University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Daniel Shu)Boston Medical Center, Boston, Massachusetts, United States
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Cancer Center - North, Kansas City, Missouri, United States
Contact: Principal Investigator (Raed Al-Rajabi)University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States
Contact: Principal Investigator (Raed Al-Rajabi)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)Siteman Cancer Center-South County, St Louis, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States
Contact: Principal Investigator (Olivia Aranha)NYP/Weill Cornell Medical Center, New York, New York, United States
Contact: Principal Investigator (Rutika Mehta)Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Michael McCormack)University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Davendra P. Sohal)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (Jordan M. Cloyd)University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States
Contact: Principal Investigator (Davendra P. Sohal)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Hassan Hatoum)University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Anwaar Saeed)Smilow Cancer Hospital Care Center - Westerly, Westerly, Rhode Island, United States
Contact: Principal Investigator (Raghav Sundar)Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Thatcher R. Heumann)UT MD Anderson - The Woodlands, Conroe, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)UT MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)UT MD Anderson - West Houston, Houston, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)UT MD Anderson - League City, League City, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
UT MD Anderson - Sugar Land, Sugar Land, Texas, United States
Contact: Principal Investigator (Hop S. Tran Cao)Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Glynn W. Gilcrease)University of Virginia Cancer Center, Charlottesville, Virginia, United States
Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303Contact: Principal Investigator (Matthew J. Reilley)VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States
Contact: Principal Investigator (Emily N. Kinsey)University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States
Contact: Principal Investigator (Jeremy Kratz)University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
Contact: Principal Investigator (Jeremy Kratz)
מובילי המחקר
Hop S Tran Cao
Principal Investigator
University of Texas MD Anderson Cancer Center LAO